Clinically Important Drug Interactions with Intravenous Anaesthetics in Older Patients

Drugs and Aging

Volumn 20, Issue 13, 2003, Pages 969-980

  Eilers, Helge ^a   Niemann, Claus U ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICONVULSIVE AGENT; ANTIFUNGAL AGENT; BARBITURIC ACID DERIVATIVE; CALCIUM ANTAGONIST; CYTOCHROME P450 1A2; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; CYTOCHROME P450 3A5; DIAZEPAM; ETOMIDATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTRAVENOUS ANESTHETIC AGENT; KETAMINE; LORAZEPAM; MACROLIDE; METHOHEXITAL; MIDAZOLAM; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; ORAL ANTIDIABETIC AGENT; PROPOFOL; PROTEINASE INHIBITOR; PROTON PUMP INHIBITOR; SEROTONIN 3 ANTAGONIST; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

AGING; APNEA; CARDIOVASCULAR EFFECT; DRUG CLEARANCE; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG METABOLISM; DRUG POTENTIATION; DRUG PROTEIN BINDING; DRUG SAFETY; GERIATRIC PATIENT; HICCUP; HUMAN; HYPOTENSION; INTRAVENOUS ANESTHESIA; PRIORITY JOURNAL; RESPIRATION DEPRESSION; REVIEW; SIDE EFFECT;

AGED; AGING; ANESTHETICS, INTRAVENOUS; BARBITURATES; BENZODIAZEPINES; DRUG INTERACTIONS; ETOMIDATE; HUMANS; KETAMINE; PROPOFOL;

EID: 0242266104     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200320130-00002     Document Type: Review

References (111)

1. Klopfenstein CE, Herrmann FR, Michel JP, et al. The influence of an aging surgical population on the anesthesia workload: a ten-year survey. Anesth Analg 1998; 86 (6): 1165-70
2. Angus DC, Kelley MA, Schmitz RJ, et al. Caring for the critically ill patient: current and projected workforce requirements for care of the critically ill and patients with pulmonary disease: can we meet the requirements of an aging population? JAMA 2000 Dec 6; 284 (21): 2762-70
3. Turnheim K. Drug dosage in the elderly: is it rational? Drugs Aging 1998; 13 (5): 357-79
4. Dodds C. Anaesthetic drugs in the elderly. Pharmacol Ther 1995; 66 (2): 369-86
5. Hammerlein A, Derendorf H, Lowenthal DT. Pharmacokinetic and pharmacodynamic changes in the elderly: clinical implications. Clin Pharmacokinet 1998 Jul; 35 (1): 49-64
6. Tumer N, Scarpace PJ, Lowenthal DT. Geriatric pharmacology: basic and clinical considerations. Annu Rev Pharmacol Toxicol 1992; 32: 271-302
7. Catterson ML, Preskorn SH, Martin RL. Pharmacodynamic and pharmacokinetic considerations in geriatric psychopharmacology. Psychiatr Clin North Am 1997; 20 (1): 205-18
8. Feely J, Coakley D. Altered pharmacodynamics in the elderly. Clin Geriatr Med 1990 May; 6 (2): 269-83
9. Fujita S. Aging and drug metabolism: alteration of liver drug metabolizing ability in male rats. Is it functional deterioration or feminization of the liver? Yakugaku Zasshi 1991 Nov; 111 (11): 627-46
10. Jones AG, Hunter JM. Anaesthesia in the elderly: special considerations. Drugs Aging 1996; 9 (5): 319-31
11. Klotz U. Effect of age on pharmacokinetics and pharmacodynamics in man. Int J Clin Pharmacol Ther 1998 Nov; 36 (11): 581-5
12. Ozdemir V, Fourie J, Busto U, et al. Pharmacokinetic changes in the elderly: do they contribute to drug abuse and dependence? Clin Pharmacokinet 1996; 31 (5): 372-85
13. Scott JC, Stanski DR. Decreased fentanyl and alfentanil dose requirements with age: a simultaneous pharmacokinetic and pharmacodynamic evaluation. J Pharmacol Exp Ther 1987 Jan; 240 (1): 159-66
14. Lemmens HJ, Bovill JG, Hennis PJ, et al. Age has no effect on the pharmacodynamics of alfentanil. Anesth Analg 1988 Oct; 67 (10): 956-60
15. Avram MJ, Krejcie TC, Niemann CU, et al. Isoflurane alters the recirculatory pharmacokinetics of physiologic markers. Anesthesiology 2000 Jun; 92 (6): 1757-68
16. Gepts E. Pharmacokinetic concepts for TCI anaesthesia. Anaesthesia 1998 Apr; 53 Suppl. 1: 4-12
17. Henthorn TK, Krejcie TC, Niemann CU, et al. Ketamine distribution described by a recirculatory pharmacokinetic model is not stereoselective. Anesthesiology 1999 Dec; 91 (6): 1733-43
18. Hull CJ. How far can we go with compartmental models? Anesthesiology 1990 Mar; 72 (3): 399-402
19. Krejcie TC, Avram MJ. What determines anesthetic induction dose? It's the front-end kinetics, doctor! Anesth Analg 1999 Sep; 89 (3): 541-4
20. Bailey JM. Technique for quantifying the duration of intravenous anesthetic effect. Anesthesiology 1995 Nov; 83 (5): 1095-103
21. Hughes MA, Glass PS, Jacobs JR. Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology 1992 Mar; 76 (3): 334-41
22. Schraag S, Mohl U, Hirsch M, et al. Recovery from opioid anesthesia: the clinical implication of context-sensitive half-times. Anesth Analg 1998 Jan; 86 (1): 184-90
23. Davidson MH. Does differing metabolism by cytochrome p450 have clinical importance? Curr Atheroscler Rep 2000; 2 (1): 14-9
24. Dresser GK, Spence JD, Bailey DG. Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition. Clin Pharmacokinet 2000 Jan; 38 (1): 41-57
25. Dresser GK, Bailey DG. A basic conceptual and practical overview of interactions with highly prescribed drugs. Can J Clin Pharmacol 2002 Winter; 9 (4): 191-8
26. Thummel KE, Wilkinson GR. In vitro and in vivo drug interactions involving human CYP3A. Annu Rev Pharmacol Toxicol 1998; 38: 389-430
27. Hemeryck A, Belpaire FM. Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update. Curr Drug Metab 2002; 3 (1): 13-37
28. Miners JO. Evolution of drug metabolism: hitchhiking the technology bandwagon. Clin Exp Pharmacol Physiol 2001; 29 (11): 1040-4
29. Rendic S. Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev 2002; 34: 83-448
30. Tanaka E. Clinically important pharmacokinetic drug-drug interactions of cytochrome P450 enzymes. J Clin Pharm Ther 1998; 23 (6): 403-16
31. Williams D, Feely J. Pharmacokinetic-pharmacodynamic drug interactions with CoA reductase inhibitors. Clin Pharmacokinet 2002; 41 (5): 343-70
32. Paspatis GA, Manolaraki M, Xirouchakis G, et al. Synergistic sedation with midazolam and propofol versus midazolam and pethidine in colonoscopies: a prospective, randomized study. Am J Gastroenterol 2002 Aug; 97 (8): 1963-7
33. Reimann FM, Samson U, Derad I, et al. Synergistic sedation with low-dose midazolam and propofol for colonoscopies. Endoscopy 2000 Mar; 32 (3): 239-44
34. Nieuwenhuijs DJ, Olofsen E, Romberg RR, et al. Response surface modeling of remifentanil-propofol interaction on cardiorespiratory control and bispectral index. Anesthesiology 2003 Feb; 98 (2): 312-22
35. Reves JG, Glass PSA, Lubarsky DA. Nonbarbiturate intravenous anesthetics. In: Miller RD, editor. Anesthesia. 5th ed. Philadelphia: Churchill Livingstone, 2000: 228-72
36. van Hemelrijck J, White PF. Nonopioid intravenous anesthesia. In: Barash PG, Cullen BF, Stoelting RK, editors. Clinical anesthesia. 3rd ed. Philadelphia: Lippincott-Raven Publishers, 1996: 311-27
37. Fragen RJ. Infusions of intravenous anesthetics. In: Fragen RJ, editor. Drug infusions in anesthesiology. 2nd ed. Philadelphia: Lippincott-Raven Publishers, 1996
38. McCollum JS, Dundee JW. Comparison of induction characteristics of four intravenous anaesthetic agents. Anaesthesia 1986 Oct; 41 (10): 995-1000
39. Hudson RJ, Stanski DR, Burch PG. Pharmacokinetics of methohexital and thiopental in surgical patients. Anesthesiology 1983 Sep; 59 (3): 215-9
40. Avram MJ, Sanghvi R, Henthorn TK, et al. Determinants of thiopental induction dose requirements. Anesth Analg 1993 Jan; 76 (1): 10-7
41. Bischoff KB, Dedrick RL. Thiopental pharmacokinetics. J Pharm Sci 1968 Aug; 57 (8): 1346-51
42. White PF. Clinical pharmacology of intravenous induction drugs. Int Anesthesiol Clin 1988 Summer; 26 (2): 98-104
43. Olsen RW. Barbiturates. Int Anesthesiol Clin 1988 Winter; 26 (4): 254-61
44. Krintel JJ, Wegmann F. Aminophylline reduces the depth and duration of sedation with barbiturates. Acta Anaesthesiol Scand 1987 May; 31 (4): 352-4
45. Stibolt O, Wachowiak-Andersen G. Altered response to intravenous thiopental and succinylcholine in acute amphetamine abuse. Acta Anaesthesiol Scand 2002 May; 46 (5): 609-10
46. Kaukinen S, Eerola M, Ylitalo P. Prolongation of thiopentone anaesthesia by probenecid. Br J Anaesth 1980 Jun; 52 (6): 603-7
47. Wilder-Smith OH, Ravussin PA, Decosterd LA, et al. Midazolam premedication and thiopental induction of anaesthesia: interactions at multiple end-points. Br J Anaesth 1999 Oct; 83 (4): 590-5
48. Lim TA, Inbasegaran K. Midazolam premedication and thiopental induction of anaesthesia. Br J Anaesth 2000 Jul; 85 (1): 175-6
49. Homer TD, Stanski DR. The effect of increasing age on thiopental disposition and anesthetic requirement. Anesthesiology 1985 Jun; 62 (6): 714-24
50. Stanski DR, Maitre PO. Population pharmacokinetics and pharmacodynamics of thiopental: the effect of age revisited. Anesthesiology 1990 Mar; 72 (3): 412-22
51. Davis AW, Heavner JE. Polypharmacy, age, and scheduled surgery. J Clin Anesth 2002 Aug; 14 (5): 329-34
52. Sear JW, Higham H. Issues in the perioperative management of the elderly patient with cardiovascular disease. Drugs Aging 2002; 19 (6): 429-51
53. Cillo JE, Jr. Propofol anesthesia for outpatient oral and maxillofacial surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 87 (5): 530-8
54. Vargo JJ, Zuccaro Jr G, Dumot JA, et al. Gastroenterologist-administered propofol versus meperidine and midazolam for advanced upper endoscopy: a prospective, randomized trial. Gastroenterology 2002 Jul; 123 (1): 8-16
55. Wehrmann T, Kokabpick S, Lembcke B, et al. Efficacy and safety of intravenous propofol sedation during routine ERCP: a prospective, controlled study. Gastrointest Endosc 1999 Jun; 49 (6): 677-83
56. Miller LJ, Wiles-Pfeifler R. Propofol for the long-term sedation of a critically ill patient. Am J Crit Care 1998 Jan; 7 (1): 73-6
57. Marinella MA. Propofol for sedation in the intensive care unit: essentials for the clinician. Respir Med 1997 Oct; 91 (9): 505-10
58. Deegan RJ. Propofol: a review of the pharmacology and applications of an intravenous anesthetic agent. Am J Med Sci 1992 Jul; 304 (1): 45-9
59. Dundee JW, Clarke RS. Propofol. Eur J Anaesthesiol 1989 Jan; 6 (1): 5-22
60. Kanto JH. Propofol, the newest induction agent of anesthesia. Int J Clin Pharmacol Ther Toxicol 1988 Jan; 26 (1): 41-57
61. Skues MA, Prys-Roberts C. The pharmacology of propofol. J Clin Anesth 1989; 1 (5): 387-400
62. Trapani G, Altomare C, Liso G, et al. Propofol in anesthesia: mechanism of action, structure-activity relationships, and drug delivery. Curr Med Chem 2000 Feb; 7 (2): 249-71
63. Shafer SL. Advances in propofol pharmacokinetics and pharmacodynamics. J Clin Anesth 1993 Nov-Dec; 5 (6 Suppl. 1): 14S-21S
64. Langley MS, Heel RC. Propofol: a review of its pharmacodynamic and pharmacokinetic properties and use as an intravenous anaesthetic. Drugs 1988 Apr; 35 (4): 334-72
65. Kirkpatrick T, Cockshott ID, Douglas EJ, et al. Pharmacokinetics of propofol (diprivan) in elderly patients. Br J Anaesth 1988 Feb; 60 (2): 146-50
66. Shafer A, Doze VA, Shafer SL, et al. Pharmacokinetics and pharmacodynamics of propofol infusions during general anesthesia. Anesthesiology 1988 Sep; 69 (3): 348-56
67. Schnider TW, Minto CF, Shafer SL, et al. The influence of age on propofol pharmacodynamics. Anesthesiology 1999 Jun; 90 (6): 1502-16
68. Carrasco G, Cabre L, Sobrepere G, et al. Synergistic sedation with propofol and midazolam in intensive care patients after coronary artery bypass grafting. Crit Care Med 1998 May; 26 (5): 844-51
69. Cressey DM, Claydon P, Bhaskaran NC, et al. Effect of midazolam pretreatment on induction dose requirements of propofol in combination with fentanyl in younger and older adults. Anaesthesia 2001 Feb; 56 (2): 108-13
70. Keita H, Peytavin G, Giraud O, et al. Aging prolongs recovery of psychomotor functions at emergence from propofol-alfentanil anaesthesia. Can J Anaesth 1998 Dec; 45 (12): 1211-4
71. Ropcke H, Konen-Bergmann M, Cuhls M, et al. Propofol and remifentanil pharmacodynamic interaction during orthopedic surgical procedures as measured by effects on bispectral index. J Clin Anesth 2001 May; 13 (3): 198-207
72. Seifert H, Schmitt TH, Gultekin T, et al. Sedation with propofol plus midazolam versus propofol alone for interventional endoscopicprocedures: a prospective, randomized study. Aliment Pharmacol Ther 2000 Sep; 14 (9): 1207-14
73. Taylor E, Ghouri AF, White PF. Midazolam in combination with propofol for sedation during local anesthesia. J Clin Anesth 1992 May-Jun; 4 (3): 213-6
74. Walder B, Borgeat A, Suter PM, et al. Propofol and midazolam versus propofol alone for sedation following coronary artery bypass grafting: a randomized, placebo-controlled trial. Anaesth Intensive Care 2002 Apr; 30 (2): 171-8
75. Giese JL, Stanley TH. Etomidate: a new intravenous anesthetic induction agent. Pharmacotherapy 1983 Sep-Oct; 3 (5): 251-8
76. Preziosi P, Vacca M. Adrenocortical suppression and other endocrine effects of etomidate. Life Sci 1988; 42 (5): 477-89
77. Arden JR, Holley FO, Stanski DR. Increased sensitivity to etomidate in the elderly: initial distribution versus altered brain response. Anesthesiology 1986 Jul 65 (1): 19-27
78. Irifune M, Shimizu T, Nomoto M, et al. Ketamine-induced anesthesia involves the N-methyl-D-aspartate receptor-channel complex in mice. Brain Res 1992 Nov 20; 596 (1-2): 1-9
79. Klepstad P, Maurset A, Moberg ER,et al. Evidence of a role for NMDA receptors in pain perception. Eur J Pharmacol 1990 Oct 23; 187 (3): 513-8
80. Oye I. Ketamine analgesia, NMDA receptors and the gates of perception. Acta Anaesthesiol Scand 1998 Aug; 42 (7): 747-9
81. Chang T, Glazko AJ. Biotransformation and disposition of ketamine. Int Anesthesiol Clin 1974 Summer; 12 (2): 157-77
82. White PF, Johnston RR, Pudwill CR. Interaction of ketamine and halothane in rats. Anesthesiology 1975 Feb; 42 (2): 179-86
83. Clements JA, Nimmo WS. Pharmacokinetics and analgesic effect of ketamine in man. Br J Anaesth 1981 Jan; 53 (1): 27-30
84. Grant IS, Nimmo WS, Clements JA. Pharmacokinetics and analgesic effects of i.m. and oral ketamine. Br J Anaesth 1981 Aug; 53 (8): 805-10
85. White PF, Way WL, Trevor AJ. Ketamine: its pharmacology and therapeutic uses. Anesthesiology 1982 Feb; 56 (2): 119-36
86. Soliman MG, Brindle GF, Kuster G. Response to hypercapnia under ketamine anaesthesia. Can Anaesth Soc J 1975 Jul; 22 (4): 486-94
87. Dundee JW, Bovill JG, Clarke RS, et al. Problems with ketamine in adults [abstract]. Anaesthesia 1971 Jan; 26 (1): 86
88. Garfield JM, Garfield FB, Stone JG, et al. A comparison of psychologic responses to ketamine and thiopental: nitrous oxide: halothane anesthesia. Anesthesiology 1972 Apr; 36 (4): 329-38
89. Kawaguchi M, Sakamoto T, Inoue S, et al. Low dose propofol as a supplement to ketamine-based anesthesia during intraoperative monitoring of motor-evoked potentials. Spine 2000 Apr 15; 25 (8): 974-9
90. Bell RF. Low-dose subcutaneous ketamine infusion and morphine tolerance. Pain 1999; 83 (1): 101-3
91. Eilers H, Philip LA, Bickler PE, et al. The reversal of fentanyl-induced tolerance by administration of "small-dose" ketamine. Anesth Analg 2001 Jul; 93 (1): 213-4
92. Greenblatt DJ. Pharmacology of benzodiazepine hypnotics. J Clin Psychiatry 1992 Jun; 53 Suppl.: 7-13
93. Paterniti S, Dufouil C, Alperovitch A. Long-term benzodiazepine use and cognitive decline in the elderly: the Epidemiology of Vascular Aging Study. J Clin Psychopharmacol 2002 Jun; 22 (3): 285-93
94. Bell GD, Spickett GP, Reeve PA, et al. Intravenous midazolam for upper gastrointestinal endoscopy: a study of 800 consecutive cases relating dose to age and sex of patient. Br J Clin Pharmacol 1987; 23 (2): 241-3
95. Gray SL, Lai KV, Larson EB. Drug-induced cognition disorders in the elderly: incidence, prevention and management. Drug Saf 1999; 21 (2): 101-22
96. Closser MH. Benzodiazepines and the elderly: a review of potential problems. J Subst Abuse Treat 1991; 8 (1-2): 35-41
97. Greenblatt DJ. Benzodiazepine hypnotics: sorting the pharmacokinetic facts. J Clin Psychiatry 1991 Sep; 52 Suppl.: 4-10
98. Greenblatt DJ, Harmatz JS, Shader RI. Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly: therapeutic considerations (Part I). Clin Pharmacokinet 1991 Sep; 21 (3): 165-77
99. Lechin F, van der Dijs B, Benaim M. Benzodiazepines: tolerability in elderly patients. Psychother Psychosom 1996; 65 (4): 171-82
100. Reves JG, Fragen RJ, Vinik HR, et al. Midazolam: pharmacology and uses. Anesthesiology 1985 Mar; 62 (3): 310-24
101. Shorr RI, Robin DW. Rational use of benzodiazepines in the elderly. Drugs Aging 1994 Jan; 4 (1): 9-20
102. Amrein R, Hetzel W. Pharmacology of Dormicum (midazolam) and Anexate (flumazenil). Acta Anaesthesiol Scand Suppl 1990; 92: 6-15
103. Mohler H, Richards JG. The benzodiazepine receptor: a pharmacological control element of brain function. Eur J Anaesthesiol Suppl 1988; 2: 15-24
104. Mohler H, Fritschy JM, Rudolph U. A new benzodiazepine pharmacology. Eur J Anaesthesiol Suppl 2002 Jan; 300 (1): 2-8
105. Forster A, Gardaz JP, Suter PM, et al. Respiratory depression by midazolam and diazepam. Anesthesiology 1980 Dec; 53 (6): 494-7
106. Alexander CM, Gross JB. Sedative doses of midazolam depress hypoxic ventilatory responses in humans. Anesth Analg 1988 Apr; 67 (4): 377-82
107. Alexander CM, Teller LE, Gross JB. Slow injection does not prevent midazolam-induced ventilatory depression. Anesth Analg 1992 Feb; 74 (2): 260-4
108. Bailey PL, Pace NL, Ashburn MA, et al. Frequent hypoxemia and apnea after sedation with midazolam and fentanyl. Anesthesiology 1990 Nov; 73 (5): 826-30
109. Olkkola KT, Aranko K, Luurila H, et al. A potentially hazardous interaction between erythromycin and midazolam. Clin Pharmacol Ther 1993 Mar; 53 (3): 298-305
110. Palkama VJ, Isohanni MH, Neuvonen PJ, et al. The effect of intravenous and oral fluconazole on the pharmacokinetics and pharmacodynamics of intravenous alfentanil. Anesth Analg 1998: 87 (1): 190-4
111. Palkama VJ, Ahonen J, Neuvonen PJ, et al. Effect of saquinavir on the pharmacokinetics and pharmacodynamics of oral and intravenous midazolam. Clin Pharmacol Ther 1999 Jul; 66 (1): 33-9